(Q35666997)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14962763%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

review article

1 reference

title

Provocation testing with recombinant allergens (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14962763%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14962763%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

author name string

Pauli G

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14962763%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

publication date

1 March 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14962763%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14962763%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14962763%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14962763%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

page(s)

281-291

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14962763%20AND%20SRC:MED&resulttype=core&format=json

Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy

23 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

7 January 2021

Recombinant allergens

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Recombinant allergens for diagnosis and therapy of allergic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

The spectrum of olive pollen allergens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Allergy to mammalian proteins: at the borderline between foreign and self?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Recombinant Aspergillus fumigatus allergens: from the nucleotide sequences to clinical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Structure and biology of stinging insect venom allergens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Cloning of three new allergens from the dust mite Lepidoglyphus destructor using phage surface display technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Recombinant spiked allergen extract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Contribution of disulphide bonds to antigenicity of Lep d 2, the major allergen of the dust mite Lepidoglyphus destructor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Recombinant Bet v 1, the major birch pollen allergen, induces hypersensitivity reactions equal to those induced by natural Bet v 1 in the airways of patients allergic to tree pollen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Reduced in vivo allergenicity of Bet v 1d isoform, a natural component of birch pollen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen Bet v 1 and to recombinant Bet v 1 wild type in skin chamber fluids collected from birch pollen–allergic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

In vitro and in vivo responses to the recombinant bovine dander allergen Bos d 2 and its fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Effects of benzalkonium chloride on innate immunity physiology of the human nasal mucosa in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique: characterization of factors influencing histamine releasability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Anti-IgE–induced accumulation of leukocytes, mediators, and albumin in skin chamber fluid from healthy and atopic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Evidence of an affinity threshold for IgE-allergen binding in the percutaneous skin test reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Precision of skin prick and puncture tests with nine methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Reproducibility of skin sensitivity using a quantitative skin prick test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Skin-prick-test-induced anaphylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Histamine reactivity of the skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Skin testing with recombinant allergens rBet v 1 and birch profilin, rBet v 2: Diagnostic value for birch pollen and associated allergies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Influence of the pollen season on immediate skin test reactivity to common allergens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

A comparison of two skin test methodologies and allergens from two different manufacturers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Skin prick test reactivity to recombinant latex allergens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

IgE reactivity to Api g 1, a major celery allergen, in a Central European population is based on primary sensitization by Bet v 1☆☆☆★

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Component-resolved diagnosis (CRD) of type I allergy with recombinant grass and tree pollen allergens by skin testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Immunological activity of recombinant Ole e 1 in patients with Olea europaea pollinosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

In vivo biological activity of recombinant Der p II allergen of house-dust mite.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Component-resolved diagnosis with recombinant allergens in patients with cherry allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Survey of fatalities from skin testing and immunotherapy 1985-1989.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Characterization of Der p V allergen, cDNA analysis, and IgE-mediated reactivity to the recombinant protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Sequence analysis and expression of a cDNA clone encoding a 98-kDa allergen in Dermatophagoides farinae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Skin-test reactivity and isotype-specific immune responses to recombinant Asp f 3, a major allergen of Aspergillus fumigatus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Skin test reactivity to 2 recombinant Aspergillus fumigatus allergens in A fumigatus-sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Type I skin reactivity to native and recombinant phospholipase A2 from honeybee venom is similar

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Brief report: evaluation of polymerized ragweed extracts by intradermal end point titration, RAST inhibition, and parallel line bioassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

IgE-binding proliferative responses and skin test reactivity to Cop c 1, the first recombinant allergen from the basidiomycete Coprinus comatus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

A standardized quantitative skin-test assay of allergen potency and stability: studies on the allergen dose-response curve and effect of wheal, erythema, and patient selection on assay results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Recombinant allergens for skin testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Different profiles in specific IgE to rBet v 1 and rBet v 2 in patients allergic to birch pollen from six countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Common epitopes of birch pollen and apples--studies by western and northern blot

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Recombinant allergen fragments as candidate preparations for allergen immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Non-anaphylactic combination of partially deleted fragments of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Reduction in IgE binding to allergen variants generated by site-directed mutagenesis: contribution of disulfide bonds to the antigenic structure of the major house dust mite allergen Der p 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Various methods for testing nasal responses in vivo: a critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Allergic rhinitis and its impact on asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

A study of some current methods for assessment of nasal histamine reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

A study of provocation tests on patients with bronchial asthma. I. The reliability of provocation tests performed under different conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

7 January 2021

The allergen challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Bronchial challenge tests in patients with asthma sensitized to cats: the importance of large particles in the immediate response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Allergen bronchial challenge tests: variability and reproducibility of the early response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Guidelines for the standardization of bronchial provocation tests with allergens. An update by an international committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Leitlinie für die Durchführung bronchialer Provokationstests mit Allergenen - Deutsche Gesellschaft für Allergologie und klinische Immunologie und Deutsche Gesellschaft für Pneumologie -

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Standardization of allergen extracts with appropriate methods. The combined use of skin prick testing and radio-allergosorbent tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Standardization of bronchial inhalation challenge procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Value of immunoglobulin E density in predicting nasal and bronchial response to inhaled allergens in rhinitic and asthmatic subjects with multiple sensitizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Allergen dose response and late symptoms in a human model of ocular allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Sustained eosinophil cationic protein release into tears after a single high-dose conjunctival allergen challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Eosinophil cationic protein in tears in allergic conjunctivitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Evaluation of a composite scoring system in conjunctival challenge with allergen: reproducibility and evolution during loratadine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Atopic conjunctivitis. A cytologic examination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

Skin prick test and serological analysis with recombinant group 2 allergens of the dust mites L. destructor and T. putrescentiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

7 January 2021

inferred from DOI database lookup

Bronchial reactivity to inhaled histamine: a method and clinical survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

7 January 2021

inferred from DOI database lookup

Cross-reactivity between deciduous trees during immunotherapy. I. In vivo results

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2003.08.007

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.YMETH.2003.08.007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14962763%20AND%20SRC:MED&resulttype=core&format=json

release_bkorngihmngxxncl3lvl7wpfny

23 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bkorngihmngxxncl3lvl7wpfny

24 November 2022

mapped directly with Wikidata item

1 reference